A short enantioselective total synthesis of 1-deoxygalactonojirimycin (migalastat) has been achieved that does not rely on chiral pool starting materials or biocatalysis. Instead, this synthesis exploits a one-pot proline-catalyzed α-chlorination and aldol reaction of a commercially available aldehyde to assemble the entire carbon skeleton in a single step. The key role played by a nitrogen protecting group in the final epoxide opening reaction is highlighted as is the amenability to access structural analogues using this route.
diabetes, and lysosomal storage disorders. [1] [2] [3] Perhaps most notably, these iminosugars have proven to be excellent inhibitors of glycosidases and glycosyltransferases 1, 3 as they bear the peripheral functionality of the parent sugar and the nitrogen atom is protonated under physiological conditions. Thus, piperdine iminosugars generate an oxycarbenium ion surrogate that mimics the transition state of the enzyme-catalyzed hydrolysis of carbohydrates (see inset, Figure 1 ). 2 For example, the polyhydroxypiperidines N-butyl-deoxynojirimycin (miglustat: 1) 4 and N-hydroxyethyldeoxynojirimycin (miglitol: 2) 5 have been approved for the treatment of type I Gaucher's disease and non-insulin-dependant diabetes, respectively. 1 Additionally, 1-deoxygalactonojirimycin (migalastat: 3), 6 a pharmacological chaperone for α-galactosidase A mutants, 7 has been approved for the treatment of Fabry disease. 1-Deoxygalactonojirimycin (3) is the reduced form of the naturally occurring iminosugar galactostatin (4) (Figure 1 ), 13 and was originally reported as a synthetic product by Paulsen in 1980. 6 Owing to its potentially useful biological activities, more than 30 total syntheses of 3 have been reported that range in length from 5 to more than 15 steps. 14-17 Many of these syntheses are related by their reliance on chiral starting materials that include various carbohydrates, 14 amino acids, 15 and tartaric acid, 16 or their use of biocatalysis to introduce key stereogenic centers. 17 Of particular note, Stubbs has reported a highly efficient 5- We have previously reported the unusual reaction depicted in Scheme 2 that involves a (S)-proline-catalyzed α-chlorination (step 1) of aliphatic aldehydes and subsequent aldol reaction (step 2) with dioxanone 8. 12, 19 Importantly, proline also catalyzes the racemization of intermediate α-chloroaldehydes and owing to the differential rates of aldol reactions of (R)-10 and (S)-10 (step 2), the aldol reaction effects a dynamic kinetic resolution (DKR), delivering synchlorohydrins 11 in good yield, diastereoselectivity and enantioselectivity. To rationalize this stereochemical outcome, we postulated that electrostatic repulsion between O and Cl atoms in the aldol transition structure (TS-2) involving (S)-10 disfavours production of the anti-
12 Exploiting this advance, we have demonstrated that synchlorohydrin products 11 are excellent building blocks for the synthesis of carbohydrates 12 and polyhydroxypyrrolidines 10c,10e (see inset, Scheme 2). Thus, we envisaged that a short synthesis of 1-deoxygalactonojirimycin could be realized that relies on a similar reaction involving a suitably
protected β-aminopropanal derivative (e.g., 9: R = CH 2 NHCbz) followed by a subsequent reductive amination/annulation event.
Scheme 2. A one-pot proline catalyzed α-chlorination and aldol reaction of aldehydes delivers versatile syn-chlorohydrin building blocks 11 for carbohydrate and iminosugar synthesis.
As depicted in Scheme 3, we were delighted to find that the (R)-proline-catalyzed α-chlorination of commercially available aldehyde 13 and subsequent aldol reaction with dioxanone 8 afforded the chlorohydrin 14 in good yield and enantiomeric excess (93% ee).
Analysis of the 1 H NMR spectrum recorded on chlorohydrin 14 (CDCl 3 , 600 MHz) revealed that this material exists as an interconverting mixture of the ketochlorohydrin 14 and two 
Preparation of 2-chloro-1,2-dideoxygalactonojirimycin (19).
A sample of the piperidine 15 (0.031 g, 0.139 mmol) was dissolved in MeOH (0.70 mL) and 1 M HCl (0.14 mL) was added. 
